IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
ImmunityBio, Inc. (IBRX) Expands ANKTIVA Access With First Commercial Use in Saudi Arabia [Yahoo! Finance]
IBRX DEADLINE: The Gross Law Firm Reminds ImmunityBio, Inc. Investors of Upcoming Securities Class Action Deadline
IBRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ImmunityBio, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
Pomerantz LLP Issues Reminder to Shareholders in ImmunityBio, Inc. of Class Action – IBRX